Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer. - Xu, Wenjing; Li, Yingqiu; Liu, Lumei; Xie, Jing; Hu, Zongren; Kuang, Shida; Fu, Xinying; Li, Bonan; Sun, Tiansong; Zhu, Congxu; He, Qinghu; Sheng, Wen (Journal of Experimental & Clinical Cancer Research (17569966), 2024)